Literature DB >> 8280684

Contrast sensitivity function in Graves' ophthalmopathy and dysthyroid optic neuropathy.

M S Suttorp-Schulten1, R Tijssen, M P Mourits, P Apkarian.   

Abstract

Contrast sensitivity function was measured by a computer automated method on 38 eyes with dysthyroid optic neuropathy and 34 eyes with Graves' ophthalmopathy only. The results were compared with 74 healthy control eyes. Disturbances of contrast sensitivity functions were found in both groups when compared with controls. The eyes affected with dysthyroid optic neuropathy showed pronounced loss of contrast sensitivity in the low frequency range, which facilitates differentiation between the two groups.

Entities:  

Mesh:

Year:  1993        PMID: 8280684      PMCID: PMC504629          DOI: 10.1136/bjo.77.11.709

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  25 in total

1.  Contrast sensitivity and the diagnosis dysthyroid optic neuropathy.

Authors:  M P Mourits; M S Suttorp-Schulten; R O Tijssen; P Apkarian
Journal:  Doc Ophthalmol       Date:  1990 Apr-Jul       Impact factor: 2.379

Review 2.  Thyroid-associated eye disease: clinical management.

Authors:  P Fells
Journal:  Lancet       Date:  1991-07-06       Impact factor: 79.321

3.  Isolating the effects of primary open-angle glaucoma on the contrast sensitivity function.

Authors:  P A Sample; P S Juang; R N Weinreb
Journal:  Am J Ophthalmol       Date:  1991-09-15       Impact factor: 5.258

4.  Orbital decompression for Graves' ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach.

Authors:  M P Mourits; L Koornneef; W M Wiersinga; M F Prummel; A Berghout; R van der Gaag
Journal:  Ophthalmology       Date:  1990-05       Impact factor: 12.079

5.  Subtle disturbances of vision after optic neuritis elicited by studying contrast sensitivity.

Authors:  R L Zimmern; F W Campbell; I M Wilkinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-05       Impact factor: 10.154

6.  Modification of the classification of the eye changes of Graves' disease.

Authors:  S C Werner
Journal:  Am J Ophthalmol       Date:  1977-05       Impact factor: 5.258

7.  Dysthyroid optic neuropathy. Clinical profile and rationale for management.

Authors:  J D Trobe; J S Glaser; P Laflamme
Journal:  Arch Ophthalmol       Date:  1978-07

8.  Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy.

Authors:  M F Prummel; M P Mourits; A Berghout; E P Krenning; R van der Gaag; L Koornneef; W M Wiersinga
Journal:  N Engl J Med       Date:  1989-11-16       Impact factor: 91.245

9.  Comparison of Snellen acuity, VER acuity, and Arden grating scores in macular and optic nerve diseases.

Authors:  H W Skalka
Journal:  Br J Ophthalmol       Date:  1980-01       Impact factor: 4.638

10.  Methylprednisolone pulse therapy in severe dysthyroid optic neuropathy.

Authors:  J R Guy; S Fagien; J P Donovan; M L Rubin
Journal:  Ophthalmology       Date:  1989-07       Impact factor: 12.079

View more
  5 in total

1.  Contrast sensitivity in 10 year old preterm and full term children: a population based study.

Authors:  E Larsson; A Rydberg; G Holmström
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

2.  Measuring contrast sensitivity in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy.

Authors:  R De Marco; G Ambrosio; G Ferrara
Journal:  Doc Ophthalmol       Date:  2000-09       Impact factor: 2.379

3.  Contrast sensitivity of thyroid associated ophthalmopathy patients without obvious optic neuropathy.

Authors:  Ümit Beden; Sümeyra Kaya; Volkan Yeter; Dilek Erkan
Journal:  ScientificWorldJournal       Date:  2013-12-24

4.  RAPD as a clinical alert for early evidence of dysthyroid optic neuropathy.

Authors:  Vinita Gupta; Sucharita Das; Shalini Mohan; Udit Chauhan
Journal:  J Family Med Prim Care       Date:  2022-01-31

5.  Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management.

Authors:  Alexander D Blandford; Dalia Zhang; Rao V Chundury; Julian D Perry
Journal:  Expert Rev Ophthalmol       Date:  2017-01-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.